ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $
ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $-0.25, Q2 Operating Income $-15.77M, Q2 ADJ EBITDA $-700 thousand